<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Several lines of evidence suggest that the cholinergic system in the hippocampus plays a pivotal roll in regulating the peripheral metabolism of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="2" ids="33567">catecholamines</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>The injection of cholinergic stimulators including neostigmine, the <z:chebi fb="0" ids="38462">acetylcholine esterase inhibitor</z:chebi>, into the third ventricle or the hippocampus induces the elevation of <z:chebi fb="105" ids="17234">glucose</z:chebi> or <z:chebi fb="2" ids="33567">catecholamines</z:chebi> in plasma in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Under stress conditions, release of <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> in the hippocampus increases, which coincides with the elevation of plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="2" ids="33567">catecholamines</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Age-related reduction in responsivity of the cholinergic system in the hippocampus has been well-documented </plain></SENT>
<SENT sid="4" pm="."><plain>The intrahippocampal neostigmine injection induces significantly attenuated responses in plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="2" ids="33567">catecholamines</z:chebi> in rats, which finding suggested that changes in cholinergic system activity in the hippocampus could result in alteration of the peripheral metabolism of <z:chebi fb="105" ids="17234">glucose</z:chebi> and <z:chebi fb="2" ids="33567">catecholamines</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>In <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, the most common type of <z:hpo ids='HP_0000726'>dementia</z:hpo>, degeneration of the hippocampal cholinergic system is one of the most robust pathological features </plain></SENT>
<SENT sid="6" pm="."><plain>Measurement of plasma <z:chebi fb="2" ids="33567">catecholamines</z:chebi> during a fasting state in groups of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> subjects, vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> subjects, and non-<z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> control subjects showed significantly lower plasma <z:chebi fb="2" ids="28918">epinephrine</z:chebi> levels in the <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> subjects </plain></SENT>
</text></document>